Trials / Not Yet Recruiting
Not Yet RecruitingNCT07103525
Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma
INSPIRE: Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
During the development phase (Aim 1), investigators will use a community-driven process to further refine a preliminary intervention design that was developed based on previous research. For the intervention phase (Aim 2), investigators will conduct a pilot randomized controlled trial of the multi-level intervention. For the individual-level component of the intervention, investigators will recruit 70 Chinese immigrant FSWs who work in MPs in Queens, NYC (n=35 intervention participants and n=35 control participants). To assess the feasibility and acceptability of intervention implementation (Aim 3), investigators will conduct in-depth qualitative interviews with 12 FSW study participants and the 2 peer advocates and focus groups with 4-5 staff from each of the 3 organizations (3 focus groups total and 12-15 focus group participants in total).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | INSPIRE Initiative | Culturally relevant, multi-level intervention designed to increase HIV testing through reducing intersectional stigma. Intervention includes series of four one-on-one conversations (45 minutes each over a six-week period) via mobile phone between the Hunter peer advocates and FSWs, which are reinforced through weekly text messages from the peer advocates and through role-model stories shared online. |
| BEHAVIORAL | Standard of Care | Standard HIV prevention information with no tailored components via one mobile phone verbal conversation with peer advocates. |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2027-11-01
- Completion
- 2028-01-01
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07103525. Inclusion in this directory is not an endorsement.